CERS
Cerus Corporation
Price Chart
Latest Quote
$2.70
+0.13 (+5.06%)
Current Price
| Previous Close | $2.57 |
| Open | $2.65 |
| Day High | $2.71 |
| Day Low | $2.59 |
| Volume | 2,613,829 |
Stock Information
| Shares Outstanding | 200.37M |
| Total Debt | $97.36M |
| Cash Equivalents | $80.42M |
| Revenue | $216.56M |
| Net Income | $-9.55M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $541.00M |
| EPS (TTM) | $-0.05 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $512.58M |
| Sales | $216.56M |
| Income | $-9.55M |
| Book/sh | $0.34 |
| Cash/sh | $0.40 |
| Employees | 261 |
Financial Ratios
| Quick Ratio | 1.02 |
| Current Ratio | 1.63 |
| Debt/Eq | 142.57 |
Returns & Margins
| ROA | -0.93% |
| ROE | -15.37% |
| Gross Margin | 52.99% |
| Operating Margin | -0.66% |
| Profit Margin | -4.41% |
Ownership
| Insider Ownership | 3.41% |
| Institutional Ownership | 74.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 2.50 |
| P/B | 8.01 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $4.67 |
Technical Indicators
| SMA20 | $2.69 |
| SMA50 | $2.43 |
| SMA200 | $2.01 |
| RSI | 34.82 |
| ATR | 0.1736 |
| Shares Float | 181.92M |
| Short Float | 5.53% |
| Short Ratio | 3.11 |
| Volatility | 1.77 |
| Rel Volume | 1.39 |
Performance History
| Week | +4.25% |
| Month | +0.00% |
| Quarter | +53.41% |
| 6 Months | +25.00% |
| YTD | +37.06% |
| Year | +106.11% |
| 3 Years | +3.45% |
| 5 Years | -54.55% |
| 10 Years | -56.03% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.70 | 3,293,100 |
| 2026-06-17 | $2.57 | 2,530,700 |
| 2026-06-16 | $2.47 | 2,179,800 |
| 2026-06-15 | $2.52 | 2,117,600 |
| 2026-06-12 | $2.56 | 2,229,700 |
| 2026-06-11 | $2.59 | 3,859,800 |
| 2026-06-10 | $2.56 | 1,840,900 |
| 2026-06-09 | $2.58 | 2,240,900 |
| 2026-06-08 | $2.60 | 1,673,000 |
| 2026-06-05 | $2.71 | 1,607,600 |
| 2026-06-04 | $2.79 | 3,134,400 |
| 2026-06-03 | $2.66 | 2,183,700 |
| 2026-06-02 | $2.70 | 2,435,200 |
| 2026-06-01 | $2.84 | 2,558,400 |
| 2026-05-29 | $3.04 | 3,291,700 |
| 2026-05-28 | $2.92 | 3,679,200 |
| 2026-05-27 | $2.82 | 1,692,100 |
| 2026-05-26 | $2.73 | 1,174,000 |
| 2026-05-22 | $2.71 | 1,730,700 |
| 2026-05-21 | $2.74 | 1,912,100 |
| 2026-05-20 | $2.69 | 3,093,400 |
| 2026-05-19 | $2.70 | 4,450,600 |
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.
đ° Latest News
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M
Insider Monkey âĸ 2026-06-16T12:53:01Z
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?
Zacks âĸ 2026-06-04T13:40:03Z
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
Insider Monkey âĸ 2026-05-23T12:16:00Z
3 Penny Stocks With Market Caps Under $500M And Promising Growth
Simply Wall St. âĸ 2026-05-20T12:05:23Z
Cerebras IPO in focus as Nvidia earnings loom
Yahoo Finance Video âĸ 2026-05-15T15:06:53Z
Cerus Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-01T12:30:00Z
Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-01T07:17:59ZCerus (CERS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-04-30T23:26:29Z
Cerus Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-30T22:16:37Z
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
Simply Wall St. âĸ 2026-04-14T18:06:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $93,845,000 | $80,748,000 | $69,967,000 | $74,954,000 |
| Cost Of Revenue | $93,845,000 | $80,748,000 | $69,967,000 | $74,954,000 |
| Total Revenue | $206,133,000 | $180,270,000 | $156,367,000 | $162,048,000 |
| Operating Revenue | $206,133,000 | $180,270,000 | $156,367,000 | $162,048,000 |
| Expenses | ||||
| Interest Expense | $8,343,000 | $8,877,000 | $8,386,000 | $5,831,000 |
| Total Expenses | $214,814,000 | $194,495,000 | $182,692,000 | $196,129,000 |
| Other Income Expense | $1,741,000 | $2,346,000 | $-2,611,000 | $-2,425,000 |
| Other Non Operating Income Expenses | $3,016,000 | $1,976,000 | $1,765,000 | $-1,735,000 |
| Net Non Operating Interest Income Expense | $-8,343,000 | $-8,877,000 | $-8,386,000 | $-5,831,000 |
| Interest Expense Non Operating | $8,343,000 | $8,877,000 | $8,386,000 | $5,831,000 |
| Operating Expense | $120,969,000 | $113,747,000 | $112,725,000 | $121,175,000 |
| Other Operating Expenses | $-27,665,000 | $-21,051,000 | $-30,430,000 | $-26,267,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-15,627,000 | $-20,918,000 | $-37,489,000 | $-42,779,000 |
| Net Interest Income | $-8,343,000 | $-8,877,000 | $-8,386,000 | $-5,831,000 |
| Normalized Income | $-14,619,750 | $-21,210,300 | $-34,031,960 | $-42,233,900 |
| Net Income From Continuing And Discontinued Operation | $-15,627,000 | $-20,918,000 | $-37,489,000 | $-42,779,000 |
| Total Operating Income As Reported | $-8,681,000 | $-14,225,000 | $-30,053,000 | $-34,081,000 |
| Net Income Common Stockholders | $-15,627,000 | $-20,918,000 | $-37,489,000 | $-42,779,000 |
| Net Income | $-15,627,000 | $-20,918,000 | $-37,489,000 | $-42,779,000 |
| Net Income Including Noncontrolling Interests | $-15,637,000 | $-20,961,000 | $-37,647,000 | $-42,825,000 |
| Net Income Continuous Operations | $-15,637,000 | $-20,961,000 | $-37,647,000 | $-42,825,000 |
| Pretax Income | $-15,283,000 | $-20,756,000 | $-37,322,000 | $-42,337,000 |
| Special Income Charges | $0 | $0 | $-3,728,000 | $0 |
| Operating Income | $-8,681,000 | $-14,225,000 | $-26,325,000 | $-34,081,000 |
| Gross Profit | $112,288,000 | $99,522,000 | $86,400,000 | $87,094,000 |
| Per Share | ||||
| Diluted EPS | $-0.08 | $-0.11 | $-0.21 | $-0.24 |
| Basic EPS | $-0.08 | $-0.11 | $-0.21 | $-0.24 |
| Other | ||||
| Tax Effect Of Unusual Items | $-267,750 | $77,700 | $-918,960 | $-144,900 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,239,000 | $-10,394,000 | $-21,961,000 | $-32,832,000 |
| Total Unusual Items | $-1,275,000 | $370,000 | $-4,376,000 | $-690,000 |
| Total Unusual Items Excluding Goodwill | $-1,275,000 | $370,000 | $-4,376,000 | $-690,000 |
| Reconciled Depreciation | $1,426,000 | $1,855,000 | $2,599,000 | $2,984,000 |
| EBITDA (Bullshit earnings) | $-5,514,000 | $-10,024,000 | $-26,337,000 | $-33,522,000 |
| EBIT | $-6,940,000 | $-11,879,000 | $-28,936,000 | $-36,506,000 |
| Diluted Average Shares | $190,594,000 | $184,563,000 | $180,270,000 | $176,545,000 |
| Basic Average Shares | $190,594,000 | $184,563,000 | $180,270,000 | $176,545,000 |
| Diluted NI Availto Com Stockholders | $-15,627,000 | $-20,918,000 | $-37,489,000 | $-42,779,000 |
| Minority Interests | $10,000 | $43,000 | $158,000 | $46,000 |
| Tax Provision | $354,000 | $205,000 | $325,000 | $488,000 |
| Restructuring And Mergern Acquisition | $0 | $0 | $3,728,000 | $0 |
| Gain On Sale Of Security | $-1,275,000 | $370,000 | $-648,000 | $-690,000 |
| Research And Development | $67,720,000 | $58,907,000 | $67,639,000 | $64,107,000 |
| Selling General And Administration | $80,914,000 | $75,891,000 | $75,516,000 | $83,335,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $62,908,000 | $54,829,000 | $51,334,000 | $66,294,000 |
| Total Assets | $221,859,000 | $200,917,000 | $197,748,000 | $218,092,000 |
| Total Non Current Assets | $47,475,000 | $48,895,000 | $53,307,000 | $47,948,000 |
| Other Non Current Assets | $26,831,000 | $32,041,000 | $32,638,000 | $23,151,000 |
| Goodwill And Other Intangible Assets | $1,316,000 | $1,316,000 | $1,316,000 | $1,316,000 |
| Current Assets | $174,384,000 | $152,022,000 | $144,441,000 | $170,144,000 |
| Other Current Assets | $5,030,000 | $3,643,000 | $3,221,000 | $4,561,000 |
| Inventory | $56,101,000 | $38,150,000 | $39,868,000 | $29,003,000 |
| Receivables | $30,374,000 | $29,777,000 | $35,500,000 | $34,426,000 |
| Accounts Receivable | $30,374,000 | $29,777,000 | $35,500,000 | $34,426,000 |
| Cash Cash Equivalents And Short Term Investments | $82,879,000 | $80,452,000 | $65,852,000 | $102,154,000 |
| Cash And Cash Equivalents | $19,961,000 | $20,266,000 | $11,647,000 | $35,585,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $63,927,000 | $63,893,000 | $68,149,000 | $34,218,000 |
| Total Debt | $96,946,000 | $98,097,000 | $95,999,000 | $87,237,000 |
| Long Term Debt And Capital Lease Obligation | $50,698,000 | $76,525,000 | $73,547,000 | $28,973,000 |
| Long Term Debt | $40,545,000 | $64,862,000 | $59,796,000 | $13,644,000 |
| Current Debt And Capital Lease Obligation | $46,248,000 | $21,572,000 | $22,452,000 | $58,264,000 |
| Current Debt | $43,343,000 | $19,297,000 | $20,000,000 | $56,159,000 |
| Other Current Borrowings | $43,343,000 | $19,297,000 | $20,000,000 | $56,159,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $156,894,000 | $144,021,000 | $144,304,000 | $149,530,000 |
| Total Non Current Liabilities Net Minority Interest | $56,093,000 | $80,413,000 | $76,783,000 | $32,472,000 |
| Other Non Current Liabilities | $5,395,000 | $3,888,000 | $3,236,000 | $3,499,000 |
| Current Liabilities | $100,801,000 | $63,608,000 | $67,521,000 | $117,058,000 |
| Current Deferred Liabilities | $1,274,000 | $1,398,000 | $2,002,000 | $589,000 |
| Payables And Accrued Expenses | $35,018,000 | $28,699,000 | $31,245,000 | $40,628,000 |
| Payables | $28,008,000 | $21,695,000 | $23,842,000 | $33,002,000 |
| Accounts Payable | $28,008,000 | $21,695,000 | $23,842,000 | $33,002,000 |
| Equity | ||||
| Common Stock Equity | $64,224,000 | $56,145,000 | $52,650,000 | $67,610,000 |
| Total Equity Gross Minority Interest | $64,965,000 | $56,896,000 | $53,444,000 | $68,562,000 |
| Stockholders Equity | $64,224,000 | $56,145,000 | $52,650,000 | $67,610,000 |
| Gains Losses Not Affecting Retained Earnings | $-156,000 | $-400,000 | $-1,274,000 | $-2,787,000 |
| Other Equity Adjustments | $-156,000 | $-400,000 | $-1,274,000 | $-2,787,000 |
| Retained Earnings | $-1,081,155,000 | $-1,065,528,000 | $-1,044,610,000 | $-1,007,121,000 |
| Other | ||||
| Ordinary Shares Number | $192,142,000 | $185,766,000 | $181,248,000 | $177,581,297 |
| Share Issued | $192,142,000 | $185,766,000 | $181,248,000 | $177,581,297 |
| Tangible Book Value | $62,908,000 | $54,829,000 | $51,334,000 | $66,294,000 |
| Invested Capital | $148,112,000 | $140,304,000 | $132,446,000 | $137,413,000 |
| Working Capital | $73,583,000 | $88,414,000 | $76,920,000 | $53,086,000 |
| Capital Lease Obligations | $13,058,000 | $13,938,000 | $16,203,000 | $17,434,000 |
| Total Capitalization | $104,769,000 | $121,007,000 | $112,446,000 | $81,254,000 |
| Minority Interest | $741,000 | $751,000 | $794,000 | $952,000 |
| Additional Paid In Capital | $1,145,343,000 | $1,121,887,000 | $1,098,353,000 | $1,077,341,000 |
| Capital Stock | $192,000 | $186,000 | $181,000 | $177,000 |
| Common Stock | $192,000 | $186,000 | $181,000 | $177,000 |
| Preferred Stock | $0 | $0 | - | - |
| Long Term Capital Lease Obligation | $10,153,000 | $11,663,000 | $13,751,000 | $15,329,000 |
| Current Deferred Revenue | $1,274,000 | $1,398,000 | $2,002,000 | $589,000 |
| Current Capital Lease Obligation | $2,905,000 | $2,275,000 | $2,452,000 | $2,105,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $18,261,000 | $11,939,000 | $11,822,000 | $17,577,000 |
| Current Accrued Expenses | $7,010,000 | $7,004,000 | $7,403,000 | $7,626,000 |
| Goodwill | $1,316,000 | $1,316,000 | $1,316,000 | $1,316,000 |
| Net PPE | $19,328,000 | $15,538,000 | $19,353,000 | $23,481,000 |
| Accumulated Depreciation | $-19,673,000 | $-18,439,000 | $-16,472,000 | $-14,216,000 |
| Gross PPE | $39,001,000 | $33,977,000 | $35,825,000 | $37,697,000 |
| Leases | $12,189,000 | $12,192,000 | $12,192,000 | $12,814,000 |
| Construction In Progress | $2,901,000 | $0 | $0 | $416,000 |
| Other Properties | $12,072,000 | $9,859,000 | $12,142,000 | $13,945,000 |
| Machinery Furniture Equipment | $11,839,000 | $11,926,000 | $11,491,000 | $10,522,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $62,918,000 | $60,186,000 | $54,205,000 | $66,569,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,108,000 | $8,522,000 | $-47,765,000 | $-27,615,000 |
| Operating Activities | ||||
| Operating Cash Flow | $4,837,000 | $11,359,000 | $-43,168,000 | $-25,615,000 |
| Cash Flow From Continuing Operating Activities | $4,837,000 | $11,359,000 | $-43,168,000 | $-25,615,000 |
| Operating Gains Losses | $284,000 | $-378,000 | $-566,000 | $4,202,000 |
| Investing Activities | ||||
| Capital Expenditure | $-3,729,000 | $-2,837,000 | $-4,597,000 | $-2,000,000 |
| Investing Cash Flow | $-6,165,000 | $-8,130,000 | $8,624,000 | $8,464,000 |
| Cash Flow From Continuing Investing Activities | $-6,165,000 | $-8,130,000 | $8,624,000 | $8,464,000 |
| Capital Expenditure Reported | $-3,729,000 | $-2,837,000 | $-4,597,000 | $-2,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $231,000 | $4,964,000 | $10,673,000 | $4,192,000 |
| Cash Flow From Continuing Financing Activities | $231,000 | $4,964,000 | $10,673,000 | $4,192,000 |
| Net Other Financing Charges | $-35,000 | $-137,000 | $-175,000 | $-104,000 |
| Repurchase Of Capital Stock | - | - | $-175,000 | $-104,000 |
| Net Common Stock Issuance | - | - | $-175,000 | $-104,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-329,000 | $-703,000 | - | - |
| Issuance Of Debt | $0 | $5,000,000 | $9,923,000 | $212,000 |
| Interest Paid Supplemental Data | $8,521,000 | $9,295,000 | $9,210,000 | $5,100,000 |
| Income Tax Paid Supplemental Data | $301,000 | $356,000 | $322,000 | $270,000 |
| End Cash Position | $20,600,000 | $21,361,000 | $13,359,000 | $37,358,000 |
| Beginning Cash Position | $21,361,000 | $13,359,000 | $37,358,000 | $51,044,000 |
| Effect Of Exchange Rate Changes | $336,000 | $-191,000 | $-128,000 | $-727,000 |
| Changes In Cash | $-1,097,000 | $8,193,000 | $-23,871,000 | $-12,959,000 |
| Proceeds From Stock Option Exercised | $595,000 | $804,000 | $925,000 | $4,084,000 |
| Net Issuance Payments Of Debt | $-329,000 | $4,297,000 | $9,923,000 | $212,000 |
| Net Long Term Debt Issuance | $-329,000 | $4,297,000 | $9,923,000 | $212,000 |
| Long Term Debt Payments | $-329,000 | $-703,000 | - | - |
| Long Term Debt Issuance | $0 | $5,000,000 | $9,923,000 | $212,000 |
| Net Investment Purchase And Sale | $-2,436,000 | $-5,293,000 | $13,221,000 | $10,464,000 |
| Sale Of Investment | $40,341,000 | $37,682,000 | $15,707,000 | $40,104,000 |
| Purchase Of Investment | $-42,777,000 | $-42,975,000 | $-2,486,000 | $-29,640,000 |
| Change In Working Capital | $-6,829,000 | $5,231,000 | $-32,035,000 | $-16,052,000 |
| Change In Other Working Capital | $-124,000 | $-603,000 | $1,413,000 | $-84,000 |
| Change In Payables And Accrued Expense | $10,000,000 | $-3,675,000 | $-16,405,000 | $-6,168,000 |
| Change In Accrued Expense | $4,275,000 | $-2,198,000 | $-9,070,000 | $-1,263,000 |
| Change In Payable | $5,725,000 | $-1,477,000 | $-7,335,000 | $-4,905,000 |
| Change In Account Payable | $5,725,000 | $-1,477,000 | $-7,335,000 | $-4,905,000 |
| Change In Prepaid Assets | $-1,627,000 | $-3,025,000 | $-994,000 | $1,168,000 |
| Change In Inventory | $-14,682,000 | $7,030,000 | $-14,947,000 | $-1,768,000 |
| Change In Receivables | $-396,000 | $5,504,000 | $-1,102,000 | $-9,200,000 |
| Changes In Account Receivables | $-396,000 | $5,504,000 | $-1,102,000 | $-9,200,000 |
| Other Non Cash Items | $2,930,000 | $2,880,000 | $2,682,000 | $2,184,000 |
| Stock Based Compensation | $22,867,000 | $22,867,000 | $20,271,000 | $24,456,000 |
| Unrealized Gain Loss On Investment Securities | $-204,000 | $-135,000 | $-170,000 | $-564,000 |
| Asset Impairment Charge | $0 | $0 | $1,698,000 | $0 |
| Depreciation Amortization Depletion | $1,426,000 | $1,855,000 | $2,599,000 | $2,984,000 |
| Depreciation And Amortization | $1,426,000 | $1,855,000 | $2,599,000 | $2,984,000 |
| Gain Loss On Investment Securities | $-6,000 | $7,000 | $54,000 | $2,291,000 |
| Net Foreign Currency Exchange Gain Loss | $290,000 | $-388,000 | $-685,000 | $1,911,000 |
| Gain Loss On Sale Of PPE | $0 | $3,000 | $65,000 | $0 |
| Net Income From Continuing Operations | $-15,637,000 | $-20,961,000 | $-37,647,000 | $-42,825,000 |
| Net Short Term Debt Issuance | - | $-703,000 | $5,091,000 | $212,000 |
| Short Term Debt Payments | - | $-703,000 | - | - |
| Common Stock Payments | - | - | $-175,000 | $-104,000 |
| Short Term Debt Issuance | - | - | $5,091,000 | $212,000 |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-18